Publications by authors named "Birgit Ehlken"

Claim this Profile
E
Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post-Authorization Safety Survey Among Physicians.
Angelika Wientzek-Fleischmann, Ulf Stellmacher, Elisabeth Beyerlein, Annegret Gohlke, Birgit Ehlken

Pharmacoepidemiol Drug Saf· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK.
Birgit Ehlken, Chihiro Nishikawa, Sigal Kaplan, Isabelle Dresco, Denis Granados

Curr Med Res Opin· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany.
Sigal Kaplan, Birgit Ehlken, Xenia Hamann

Curr Med Res Opin· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain.
Birgit Ehlken, Massoud Toussi, Abdus Samad, Sigal Kaplan, Mónika Domahidy

J Clin Pharm Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study
.
Birgit Ehlken, Margarita Shlaen, Maria Del Pilar Lopez Fuensalida de Torres, Michie Hisada, Dimitri Bennett

Int J Clin Pharmacol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' reply to Schaffalitzky de Muckadell and colleague's Comment on "Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017".
Birgit Ehlken, Lennart Nathell, Annegret Gohlke, Derya Bocuk, Massoud Toussi

Drug Saf· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.
Birgit Ehlken, Lennart Nathell, Annegret Gohlke, Derya Bocuk, Massoud Toussi

Drug Saf· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany.
Sigal Kaplan, Birgit Ehlken, Xenia Hamann

Curr Med Res Opin· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
Jan Beyer-Westendorf, Birgit Ehlken, Thomas Evers

Europace· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Diana M Eccles, Judith Balmaña, Joe Clune, Birgit Ehlken, Annegret Gohlke

Adv Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.
Craig I Coleman, Matthias Antz, Birgit Ehlken, Thomas Evers

Int J Cardiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Zaza Katsarava, Birgit Ehlken, Volker Limmroth, Kirsi Taipale, Sarita Noemi Patel

BMC Neurol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany--results of a database analysis from May 2010 to April 2012.
Birgit Ehlken, Anastassia Anastassopoulou, Johannes Hain, Claudia Schröder, Klaus Wahle

BMC Public Health· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.
Angelika Böhme, Johannes Atta, Sabine Mousset, Birgit Ehlken, Margarita Shlaen

Eur J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.
Björn Wefer, Birgit Ehlken, Jörn Bremer, Harald Burgdörfer, Burkhard Domurath

World J Urol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Florian Lordick, Birgit Ehlken, Angela Ihbe-Heffinger, Karin Berger, Karl J Krobot

Eur J Cancer· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland.
Ivo M Foppa, Wilfried Karmaus, Birgit Ehlken, Martin Fruhwirth, Ulrich Heininger

Infect Control Hosp Epidemiol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.
Birgit Ehlken, Gabriele Ihorst, Barbara Lippert, Angela Rohwedder, Gudula Petersen

Eur J Pediatr· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany.
Karin Berger, Birgit Ehlken, Barbara Kugland, Matthias Augustin

J Dtsch Dermatol Ges· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis